南京医药
(600713)
| 流通市值：66.28亿 | | | 总市值：67.41亿 |
| 流通股本：12.87亿 | | | 总股本：13.09亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,691,993,785.87 | 2,305,578,020.15 | 2,305,395,534.94 | 4,562,612,055.88 |
| 交易性金融资产 | 290,513,753.42 | 82,029,879.45 | 340,353,888.89 | - |
| 应收票据及应收账款 | 16,835,172,848.33 | 17,335,632,897.77 | 17,494,810,620.82 | 12,582,396,506.15 |
| 其中：应收票据 | 332,484,707.11 | 387,135,971.38 | 1,079,210,227.04 | 572,086,054.27 |
| 应收账款 | 16,502,688,141.22 | 16,948,496,926.39 | 16,415,600,393.78 | 12,010,310,451.88 |
| 应收款项融资 | 3,449,379,619.46 | 2,259,642,132.48 | 2,162,327,317.66 | 2,515,275,629.48 |
| 预付款项 | 1,050,095,194.08 | 969,136,593.58 | 991,831,195.07 | 889,508,713.42 |
| 其他应收款合计 | 947,804,648.71 | 935,027,654.56 | 810,848,658.59 | 812,089,253.74 |
| 存货 | 6,608,449,719.38 | 6,160,968,919.38 | 6,276,599,451.46 | 6,285,916,964.92 |
| 其他流动资产 | 130,016,789.9 | 140,591,521.27 | 134,354,436.97 | 160,062,617.01 |
| 流动资产合计 | 31,003,426,359.15 | 30,188,607,618.64 | 30,516,521,104.4 | 27,807,861,740.6 |
| 非流动资产: | | | | |
| 长期股权投资 | 67,841,370.7 | 67,514,280.13 | 70,054,150.73 | 70,566,432.63 |
| 其他权益工具投资 | 210,069,510.34 | 199,219,000.44 | 202,049,568.24 | 212,900,078.14 |
| 投资性房地产 | 85,271,769.44 | 85,738,896.23 | 88,888,834.93 | 89,281,397.55 |
| 固定资产 | 1,360,061,565.81 | 1,381,531,327.81 | 1,402,981,219.99 | 1,415,854,506.28 |
| 在建工程 | 382,257,799.96 | 342,987,857.2 | 262,924,740.37 | 237,272,905.69 |
| 使用权资产 | 306,641,668.52 | 321,201,072.09 | 340,567,202.71 | 232,079,672.03 |
| 无形资产 | 204,561,924.97 | 207,335,425.19 | 211,278,511.8 | 215,684,191.83 |
| 开发支出 | 34,191,415.17 | 29,854,112.92 | 21,849,873.95 | 18,437,891.78 |
| 商誉 | 72,166,924.65 | 72,166,924.65 | 72,166,924.65 | 72,166,924.65 |
| 长期待摊费用 | 50,996,088.47 | 48,097,820.86 | 44,481,732.46 | 44,630,617 |
| 递延所得税资产 | 264,870,208.71 | 257,629,604.1 | 232,195,688.73 | 243,434,087.67 |
| 其他非流动资产 | 2,697,577.56 | 3,911,204.71 | 13,489,702.42 | 13,456,486.67 |
| 非流动资产合计 | 3,041,627,824.3 | 3,017,187,526.33 | 2,962,928,150.98 | 2,865,765,191.92 |
| 资产总计 | 34,045,054,183.45 | 33,205,795,144.97 | 33,479,449,255.38 | 30,673,626,932.52 |
| 流动负债: | | | | |
| 短期借款 | 3,996,431,909.44 | 3,839,791,014.02 | 4,477,208,119.57 | 2,044,519,083.58 |
| 应付票据及应付账款 | 10,134,786,340.16 | 10,165,892,727.37 | 10,059,399,785.61 | 10,175,570,479.87 |
| 其中：应付票据 | 2,327,640,310.21 | 2,514,759,497.67 | 2,598,019,480.88 | 2,824,699,028.16 |
| 应付账款 | 7,807,146,029.95 | 7,651,133,229.7 | 7,461,380,304.73 | 7,350,871,451.71 |
| 合同负债 | 268,637,206.82 | 240,312,221.79 | 276,044,079.98 | 278,668,232.77 |
| 应付职工薪酬 | 133,748,176.85 | 131,243,110.36 | 158,758,946.06 | 240,577,997.14 |
| 应交税费 | 179,000,113.67 | 256,309,413.47 | 177,370,549.38 | 216,510,402.2 |
| 其他应付款合计 | 2,316,215,940.76 | 2,146,751,197.2 | 2,773,775,735.04 | 2,003,792,287.23 |
| 一年内到期的非流动负债 | 287,276,939.24 | 278,723,049.15 | 79,238,470.65 | 980,609,433.81 |
| 其他流动负债 | 4,129,446,445.06 | 3,637,656,022.22 | 1,625,444,068.47 | 1,153,464,610.31 |
| 流动负债合计 | 21,445,543,072 | 20,696,678,755.58 | 19,627,239,754.76 | 17,093,712,526.91 |
| 非流动负债: | | | | |
| 长期借款 | - | - | 200,000,000 | 200,000,000 |
| 应付债券 | 4,120,772,719.45 | 4,112,126,302.51 | 5,113,621,407.02 | 5,139,167,483.9 |
| 租赁负债 | 190,856,499.01 | 215,068,870.64 | 226,030,861.91 | 116,178,710.59 |
| 递延收益 | 266,962,608.04 | 269,490,414.73 | 273,563,417.15 | 277,616,419.57 |
| 递延所得税负债 | 62,692,888.35 | 58,436,141.85 | 32,434,136.15 | 59,053,677.54 |
| 非流动负债合计 | 4,641,284,714.85 | 4,655,121,729.73 | 5,845,649,822.23 | 5,792,016,291.6 |
| 负债合计 | 26,086,827,786.85 | 25,351,800,485.31 | 25,472,889,576.99 | 22,885,728,818.51 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,308,929,289 | 1,308,916,414 | 1,309,326,040 | 1,309,326,040 |
| 其他权益工具 | 6,677,711.17 | 6,678,258.97 | 8,939,046.75 | 8,939,046.75 |
| 资本公积 | 2,454,486,224.26 | 2,450,143,350.44 | 2,467,121,972.6 | 2,465,733,066.47 |
| 减:库存股 | 48,343,823.35 | 48,343,823.35 | 12,125,532.26 | 20,903,333.6 |
| 其他综合收益 | 100,277,613.24 | 100,742,412.88 | 95,418,435.44 | 102,296,529.74 |
| 盈余公积 | 322,368,865.27 | 322,368,865.27 | 322,368,865.27 | 322,368,865.27 |
| 未分配利润 | 2,829,769,988.57 | 2,719,075,476.14 | 2,827,627,765.5 | 2,650,266,792.49 |
| 归属于母公司股东权益合计 | 6,974,165,868.16 | 6,859,580,954.35 | 7,018,676,593.3 | 6,838,027,007.12 |
| 少数股东权益 | 984,060,528.44 | 994,413,705.31 | 987,883,085.08 | 949,871,106.89 |
| 股东权益合计 | 7,958,226,396.6 | 7,853,994,659.66 | 8,006,559,678.38 | 7,787,898,114.01 |
| 负债和股东权益合计 | 34,045,054,183.45 | 33,205,795,144.97 | 33,479,449,255.38 | 30,673,626,932.52 |
| 公告日期 | 2025-10-31 | 2025-08-30 | 2025-04-30 | 2025-04-10 |
| 审计意见(境内) | | | | 标准无保留意见 |